Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Severe cutaneous drug toxicity following disitamab vedotin treatment for metastatic gastric cancer: a case report
View through CrossRef
BackgroundThis study reports a case of severe cutaneous toxicity in a patient with metastatic gastric cancer induced by disitamab vedotin, emphasizing the need for careful monitoring and management in such treatments.Case presentationA 71-year-old female was admitted to hospital complaining of serious rashes following the first cycle of disitamab vedotin regimen for metastatic gastric cancer. The doctor diagnosedtoxic epidermal necrolysis (TEN) induced by the drug. The patient received high-dose methylprednisolone due to the side effects. This resulted in a gradual improvement of symptoms.ConclusionDuring the use of disitamab vedotin, patients need to be monitored for severe skin toxicity.
Title: Severe cutaneous drug toxicity following disitamab vedotin treatment for metastatic gastric cancer: a case report
Description:
BackgroundThis study reports a case of severe cutaneous toxicity in a patient with metastatic gastric cancer induced by disitamab vedotin, emphasizing the need for careful monitoring and management in such treatments.
Case presentationA 71-year-old female was admitted to hospital complaining of serious rashes following the first cycle of disitamab vedotin regimen for metastatic gastric cancer.
The doctor diagnosedtoxic epidermal necrolysis (TEN) induced by the drug.
The patient received high-dose methylprednisolone due to the side effects.
This resulted in a gradual improvement of symptoms.
ConclusionDuring the use of disitamab vedotin, patients need to be monitored for severe skin toxicity.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Brentuximab Vedotin As First Line Salvage Therapy in Relapsed/Refractory HL
Brentuximab Vedotin As First Line Salvage Therapy in Relapsed/Refractory HL
Abstract
Abstract 3699
Background:
A defining feature of HL is CD30 expression by Reed-Sternberg cells. Brentuxim...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Analysis of Related Risk Factors and Prognostic Factors of Gastric Cancer with Bone Metastasis: A SEER-Based Study
Analysis of Related Risk Factors and Prognostic Factors of Gastric Cancer with Bone Metastasis: A SEER-Based Study
Background. Gastric cancer is among the most common malignant tumors at home and abroad, because its early symptoms are mostly insidious, which leads to distant metastasis when gas...
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Abstract
Introduction
Schwannomas are slow-growing, subclinical neoplasms rarely found in the gastrointestinal tract. This study reports a schwannoma in the pyloric region of the s...
Aquaporin 3 Expression Pattern in Gastric Diseases and its significance
Aquaporin 3 Expression Pattern in Gastric Diseases and its significance
Abstract
Background
Aquaporin 3(AQP3) has been implicated in gastric intestinal metaplasia and gastric cancer, and considered as a biomarker to improve treatment strategy....
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
YAP1 and downstream gene alterations in metastatic breast cancer.
YAP1 and downstream gene alterations in metastatic breast cancer.
e13121
Background:
Metastatic breast cancer remains a major clinical challenge, characterized by poor prognosis and limited therapeuti...